Skandinaviska Enskilda Banken (SEB)
CYTK icon

Skandinaviska Enskilda Banken (SEB)’s Cytokinetics CYTK Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88,684
Closed -$5.64M – 305
2025
Q4 		$5.64M Sell
88,684
-61,273
-41% -$3.81M 0.02% 395
2025
Q3 		$8.24M Buy
149,957
+110,568
+281% +$4.55M 0.03% 318
2025
Q2 		$1.3M Sell
39,389
-111,519
-74% -$3.88M 0.01% 626
2025
Q1 		$6.06M Sell
150,908
-31,218
-17% -$1.43M 0.03% 374
2024
Q4 		$8.59M Buy
182,126
+26,332
+17% +$1.37M 0.04% 318
2024
Q3 		$8.22M Hold
155,794
– – 0.04% 305
2024
Q2 		$8.44M Hold
155,794
– – 0.04% 287
2024
Q1 		$10.9M Buy
155,794
+126,348
+429% +$9.77M 0.05% 257
2023
Q4 		$2.46M Sell
29,446
-21,695
-42% -$786K 0.01% 536
2023
Q3 		$1.51M Hold
51,141
– – 0.01% 605
2023
Q2 		$1.67M Buy
51,141
+5,028
+11% +$186K 0.01% 593
2023
Q1 		$1.62M Sell
46,113
-2,238
-5% -$91.3K 0.01% 593
2022
Q4 		$2.21M Sell
48,351
-2,801
-5% -$121K 0.02% 515
2022
Q3 		$2.48M Sell
51,152
-7,949
-13% -$383K 0.02% 491
2022
Q2 		$2.32M Hold
59,101
– – 0.02% 534
2022
Q1 		$2.18M Hold
59,101
– – 0.01% 607
2021
Q4 		$2.69M Hold
59,101
– – 0.01% 577
2021
Q3 		$2.11M Buy
+59,101
New +$1.74M 0.01% 633

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s CYTK Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 88,684 shares — an estimated $5.64M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CYTK in Q3 2021 and held it in 18 quarters. The position peaked at $10.9M in Q1 2024. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 88,684 Cytokinetics shares in Q1 2026, an estimated $5.64M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Cytokinetics in Q3 2021 and held it in 18 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Cytokinetics position peaked at $10.9M in Q1 2024.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.